About Regulatory News
What changed, and what it means.
Regulatory News reports the developments that move regulated work — FDA, EMA, MHRA, EU MDR and IVDR, and ICH — sourced to the primary record and written for the professionals who act on it. Publishing since 15 July 2026.
Most of what circulates as regulatory news is a summary of a summary — and the compression is where the errors live.
The premise is narrow on purpose. Regulatory professionals are not short of commentary; they are short of time, and short of anyone willing to read the actual instrument and say plainly what it does and does not say.
So that is the job: read the Official Journal notice, the Federal Register entry, the guidance PDF — the document itself — and report what changed, what it means, and what remains unresolved, in that order. Every factual claim links to the record it comes from, never to another outlet’s write-up of it.
When we get something wrong, the correction is appended to the story, dated, and listed on the corrections page. We do not silently edit a published story to make an error disappear. A publication that quietly rewrites its record has nothing left worth reading.
Six standards, load-bearing.
Not aspirations — the rules each story is written and edited against. Readers act on this material, so the standards are built for people who act.
Sourced to the primary record
Every factual claim links to the document it comes from — the Official Journal, the Federal Register, the guidance PDF — not to another outlet’s write-up of it.
The fact, the meaning, the caveat
What changed comes first. What it means comes second. What is still unresolved is stated rather than smoothed over.
We say when it is unknown
A well-drawn boundary around what has not been decided is more useful than a confident guess — we would rather publish the boundary.
Reporting is not advice
News reports what happened. Anything arguing for a course of action is labeled Analysis. You should always know which you are reading.
Named bylines
A person is accountable for every story — by name, on the page, every time.
Dates are load-bearing
Every story carries a publish date and an honest modified date, because readers schedule real work against this material.
Independence, in writing.
Regulatory News is published by Regulatory Leadership Partners. Here is exactly what that does — and does not — mean.
The publisher is disclosed, up front
Regulatory Leadership Partners places senior regulatory and quality leaders into pharma, biotech, and device organizations. A reader who works that out on their own would rightly discount everything we have published — the disclosure is the only basis on which the reporting is worth anything.
Stories are chosen for readers
Coverage is decided by what a regulatory professional needs to know, not by what the publisher sells. Articles do not pitch services, and the link at the end of a story invites you to read another story.
Paid content is labeled — loudly
Sponsored articles carry the Sponsored label wherever they appear and never occupy editorial trust slots. The rules are public in the sponsored content policy.
Conflicts get more care, not less
Where a subject touches the publisher’s commercial interests, that is a reason for additional scrutiny of the story — and we say so when it matters.
Hold us to it.
Corrections, tips, and complaints all reach a person. Corrections get read first.
editor@regulatorynews.com · published by Regulatory Leadership Partners